Ahora, los cientficos estn viendo si los GLP-1 tambin podran ayudar a las personas con diabetes tipo 1, no para reemplazar a la insulina, sino para ayudar a que otras hormonas del cuerpo hagan mejor su trabajo
Abstract Aims/hypothesis The aim of this study was to evaluate the efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes insufficiently controlled with diet and exercise alone
Current evidence supports their use in patients with obesity or overweight status combined with weight-related conditions, though prescribing varies by healthcare setting and individual patient factors
/mned 2-6 konti 100 timer/mned pr
Many people in the Canadian research community report that tracking protein intake transformed their results
Semaglutide at 2.4mg weekly (Wegovy) produces average weight loss of 15-17% in clinical trials, with many patients losing more than 20% of body weight
